Insulin infusion reduces hepatocyte growth factor in lean humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Barbora de Courten
  • Maximilian de Courten
  • Sonia Dougherty
  • Josephine M Forbes
  • Jenna R Potts
  • Robert V Considine
OBJECTIVE: Plasma Hepatocyte Growth Factor (HGF) is significantly elevated in obesity and may contribute to vascular disease, metabolic syndrome or cancer in obese individuals. The current studies were done to determine if hyperinsulinemia increases plasma HGF. MATERIALS/METHODS: Twenty-two participants (10 women/12 men, BMI 20.6-34.5 kg/m(2), age 18-49 years) underwent a hyperinsulinemic euglycemic clamp with measurement of HGF at baseline and steady state. Relationships between baseline HGF, anthropometrics, triglycerides, liver enzymes, c-reactive protein and adiponectin were also evaluated. RESULTS: Fasting HGF was positively correlated (P
OriginalsprogEngelsk
TidsskriftMetabolism
Vol/bind62
Udgave nummer5
Sider (fra-til)647-650
Antal sider4
ISSN0026-0495
DOI
StatusUdgivet - maj 2013

ID: 43232861